Scioto Biosciences leverages discovery to improve lives. Good bacteria in our bodies have the potential to promote health and treat disease. Science suggests now that many disorders previously not considered GI disorders may indeed be connected to the gut and the ecology of the microbiome. Scioto is developing SB-121 for the treatment of patients with Autism and other GI disorders. Our hope is that SB-121 will be a safe and efficacious option for this patient group.